AttendMe Owl Logo
AttendMe
Evidence Evolution
Plastic SurgeryPlastic Surgery

How This Evidence Evolved

Negative Pressure Wound Therapy

The rise of NPWT and the evidence for closed-incision applications

30.4

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Argenta and Morykwas described vacuum-assisted closure in a 1997 clinical report. An open-cell foam dressing was placed in the wound cavity and controlled pressure of 125 mmHg below ambient pressure was applied. The report included 300 wounds: 175 chronic, 94 subacute and 31 acute. Of these, 296 responded favourably, with an increased rate of granulation tissue formation. This clinical experience established neither a randomized comparison nor the size of a treatment effect against alternative wound care. Later comparative studies need to be interpreted within their particular wound populations.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Blume and colleagues’ 2008 multicenter trial enrolled 342 patients with diabetic foot ulcers and compared NPWT with advanced moist wound therapy. Complete ulcer closure within 112 days occurred in 43.2% versus 28.9% (P=0.007). In contrast, the WOLLF trial enrolled 460 patients with severe open lower-limb fractures and found no difference in surgical site infections or other complications during 12 months after surgery. A 2014 Cochrane review assessed surgical wounds expected to heal by primary intention, including grafts and closed wounds. Its nine trials included 785 participants; evidence for effects on surgical site infection, dehiscence, and time to complete healing remained unclear.
Extension

Follow-up studies, subgroup analyses, and real-world validation

NPWT has been studied after primary closure and at skin-grafted donor sites. The 2014 Cochrane review found unclear evidence for preventing infection or dehiscence, with unclear or high risk of bias in all included trials. Its 2022 update found moderate-certainty evidence of fewer surgical-site infections after primary closure (8.7% versus 11.75%; RR 0.73, 95% CI 0.63–0.85), probably little or no dehiscence difference, and possible increased blistering. Separately, a 2019 trial randomized 24 radial-forearm free-flap patients with skin grafts to portable, single-use NPWT at 80 mmHg or static dressings. Hand function favored NPWT at 7 days (P=0.016), without a graft-complication difference. These donor-site results address a specific setting.
Guidelines

Integration into clinical practice guidelines and recommendations

NICE Medical Technologies Guidance: PICO Negative Pressure Wound Therapy
Now

Current standard of care and ongoing research directions

NPWT evidence varies by wound population. Blume found more complete closures in diabetic foot ulcers, while WOLLF found no clinical or economic benefit after severe open lower-limb fractures. The 2022 primary-closure review found probable SSI reduction, little or no dehiscence difference and possible increased blistering; cost-effectiveness differed by indication. Questions remain about prophylactic closed-incision use, pressure and continuous versus intermittent modes, and instillation for infected wounds. Could wound-monitoring sensors or biodegradable fillers improve outcomes? These questions do not establish benefits for newer devices.

Landmark Trials in This Story

Argenta-Morykwas VAC1997Landmark

Vacuum-assisted closure: a new method for wound control and treatment: clinical experience

Granulation tissue response in 300 treated wounds

Annals of plastic surgeryClinical case seriesN=300
Blume 20082008

Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.

Complete ulcer closure within 112 days: NPWT 43.2% versus advanced moist wound therapy 28.9% (P=0.007).

Diabetes careMulticenter randomized controlled trialN=342
WOLLF2018Landmark

Negative-pressure wound therapy versus standard dressings for adults with an open lower limb fracture: the WOLLF RCT

Disability Rating Index at 12 months

Health technology assessment (Winchester, England)RCTN=460
Cochrane primary-intention wounds 20142014

Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.

Postoperative surgical site infection, dehiscence, and time to complete healing: NPWT versus other dressings.

The Cochrane database of systematic reviewsSystematic review of randomized trialsN=785
Forearm donor-site NPWT2019

Donor site morbidity following radial forearm free flap reconstruction with split thickness skin grafts using negative pressure wound therapy.

Self-reported MHQ hand function at 7 days: negative-pressure versus static-pressure dressings (P=0.016).

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-facialeRandomized controlled trialN=24
Plastic and reconstructive surgery. Global open 2019

Negative Pressure Wound Therapy Instillation for Management of Intrathoracic Chronic Infection

NPWT instillation for chronic intrathoracic infection

Plastic and reconstructive surgery. Global open
Cochrane primary-closure NPWT 20222022

Negative pressure wound therapy for surgical wounds healing by primary closure.

Surgical-site infection after primary closure: NPWT 8.7% vs standard dressings 11.75% (RR 0.73, 95% CI 0.63–0.85); wound dehiscence RR 0.97 (95% CI 0.82–1.16)

Systematic review of randomized controlled trialsN=13,340

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Frequently Asked Questions

What is the evidence that NPWT actually improves wound healing?+
Evidence varies by wound type. Blume’s diabetic foot ulcer trial found closure in 43.2% with NPWT versus 28.9% with advanced moist wound therapy within 112 days (P=0.007). WOLLF found no infection difference over 12 months after severe open lower-limb fractures. The 2014 Cochrane review found unclear evidence for preventing infection or dehiscence in surgical wounds healing by primary intention.
Should NPWT be used on closed surgical incisions?+
The 2014 Cochrane review found unclear SSI evidence after primary closure; the 2022 update found probable SSI reduction, with cost-effectiveness differing by indication.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026